Please assess the completion status of the following clinical trial:

Trial Title: LIFEGUARD Study - Continuous Respiratory Monitoring on the General Ward

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Non-cardiac post-surgical patients at high risk of developing respiratory and cardiovascular events (High or intermediate risk for postoperative pulmonary complications).~* Adult age (≥18 year old).~* Patient is able and willing to give informed consent.~Exclusion Criteria:~* Expected ward length of stay ≤24 hours.~* Post-surgical patients with American Society of Anesthesiologists physical status (ASA PS) V or higher.~* Ventilated or intubated patients.~* Patient is unwilling or unable to comply fully with study procedures due to any disease condition which can raise doubt about compliance~* Patient is a member of a vulnerable population regardless of authorized representative support.~* Patient is participating in another potentially confounding drug or device clinical study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Capnostream 20 (Type: OTHER): Continuous monitoring of CO2
- PM1000N-RR (Type: OTHER): Continuous monitoring of SpO2

Based on this trial design, predict the completion outcome and termination type (if applicable).